SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

Summary

SciSparc's subsidiary NeuroThera Labs completed a C$5.4 million financing round in which SciSparc invested C$2.7 million, increasing its stake to approximately 44.6% of the subsidiary's outstanding shares with a valuation of approximately C$30 million.